Anavex Life Sciences Corp (AVXL)

[sokol]

Conceivably, AVXL 2-73 may obtain additional exclusivity because of this: House Bill 1223
Bill to Amend FD&C Act to authorization extension of exclusivity periods for certain drugs that are approved for a new indication for a rare disease or condition. Introduced by Rep. Bilirakis (R-FL); Rep. Butterfield (D-NC); Rep. McCaul (R-TX)

This bill was introduced Feb. 27. The full text is not available yet.